首页> 外文期刊>BMC Nephrology >Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis
【24h】

Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis

机译:非甾体类抗炎药诱导社区住宅的急性肾损伤,患有慢性肾病的普通人口和患有慢性肾病的人:系统审查和荟萃分析

获取原文
获取外文期刊封面目录资料

摘要

Background Non-steroidal anti-inflammatory drugs (NSAIDs) are a common cause of adverse drug events (ADEs), but renal risks of NSAIDs are less well quantified than gastrointestinal and cardiac risks. This paper reports a systematic review of published population-based observational studies examining the risk of acute kidney injury (AKI) associated with NSAIDs in community-dwelling adults and those with pre-existing chronic kidney disease (CKD). Methods MEDLINE and EMBASE databases were searched until June 2016, and 3789 papers screened. Ten studies reporting NSAID risk of AKI in the general population were included in random effects meta-analysis, of which five additionally reported NSAID risk in people with CKD. Results In the general population, the pooled odds ratio (OR) of AKI for current NSAID exposure was 1.73 (95%CI 1.44 to 2.07), with somewhat higher risk observed in older people (OR 2.51, 95%CI 1.52 to 2.68). In people with CKD, individual study OR of AKI due to current NSAID exposure ranged from 1.12 to 5.25, with pooled estimate OR 1.63 (95% CI 1.22 to 2.19). Conclusions No study reported baseline risk of AKI in different populations meaning absolute risks could not be estimated, but baseline risk and therefore the absolute risk of NSAID exposure is likely to be higher in people with CKD and older people. Large population based studies measuring AKI using current definitions and estimating the absolute risk of harm are needed in order to better inform clinical decision making.
机译:背景技术非甾体抗炎药(NSAID)是不良药物事件(脂肪)的常见原因,但NSAID的肾风险比胃肠道和心脏风险较差。本文报告了对发表的基于人口的观察研究进行了系统审查,检查了与NSAIDs中的急性肾损伤(AKI)与NSAIDs中的急性肾脏损伤(AKI)的风险以及具有预先存在的慢性肾病(CKD)的风险。方法搜索MEDLINE和EMBASE数据库,直到2016年6月,3789篇论文筛选。报告一般人群中AKI的NSAID风险的十项研究包括在随机效应中,其中五个另外报告了CKD人民的NSAID风险。结果普通群体,汇总的赔率比(OR)为目前的NSAID暴露为1.73(95%CI 1.44至2.07),在老年人(或2.51,95%CI 1.52至2.68)中观察到略高。在CKD的人们中,由于目前的NSAID曝光为1.12到5.25,因此汇总估计或1.63(95%CI 1.22至2.19),因此,个人研究或AKI结论尚未研究报告不同人群中AKI的基线风险,这意味着无法估计绝对风险,而是基线风险,因此NSAID暴露的绝对风险可能会在CKD和老年人的人们中更高。需要使用电流定义和估算危害绝对危害的AKI的大型人口研究,以便更好地通知临床决策。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号